COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,889 Articles (22,568 medRxiv, 8,321 bioRxiv)

Most recent first Previous |  Page 652: Articles 6511-6520  | Next

Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously
Jin, L., Tang, R., Wu, S., Guo, X., Hou, L., Chen, X., Zhu, T., Gou, J., Huang, H., Zhong, J., Pan, H., Cui, L., chen, Y., Xia, X., Feng, J., Wang, X., Zhao, Q., Xu, X., Li, Z., Zhang, X., Li, J., Chen, W., Zhu, F.-C.
10.1101/2022.07.26.22278072 — Posted: 2022-07-28
Environmental Stability of Enveloped Viruses is Impacted by the Initial Volume and Evaporation Kinetics of Droplets
Lakdawala, S., French, A. J., Longest, A. K., Pan, J., Vikesland, P., Duggal, N. K., Marr, L.
10.1101/2022.07.26.501658 — Posted: 2022-07-27
COVID19-vaccination affects breath methane dynamics
Polag, D., Keppler, F.
10.1101/2022.07.27.501717 — Posted: 2022-07-27
Honokiol inhibits SARS-CoV-2 replication in cell culture
Salgado-Benvindo, C., Leijs, A. A., Thaler, M., Tas, A., Arbiser, J. L., Snijder, E. J., van Hemert, M. J.
10.1101/2022.07.26.501656 — Posted: 2022-07-27
High Frequencies of Phenotypically and Functionally Senescent and Exhausted CD56+CD57+PD-1+ Natural Killer Cells, SARS-CoV-2-Specific Memory CD4+ and CD8+ T cells Associated with Severe Disease in Unvaccinated COVID-19 Patients
BenMohamed, L., Srivastava, R., Dhanushkodi, N., Prakash, S., Coulon, P.-G., Vahed, H., Zayou, L., Quadiri, A.
10.1101/2022.07.26.501655 — Posted: 2022-07-27
Large-scale web scraping for problem gambling research: a case study of COVID-19 lockdown effects in Germany
Smith, E., Michalski, S., Knauth, K. H. K., Kaspar, K., Reiter, N., Peters, J.
10.1101/2022.07.27.22277642 — Posted: 2022-07-27
SARS-CoV-2 Non-Structural Protein 1(NSP1) Mutation Virulence and Natural Selection: Evolutionary Trends in the Six Continents
Salami Ghaleh, S., Rahimian, K., Mahmanzar, M., Mahdavi, B., Tokhanbigli, S., Mollapour Sisakht, M., Farhadi, A., Mousakhan Bakhtiari, M., Lee Kuehu, D., Deng, Y.
10.1101/2022.07.22.501212 — Posted: 2022-07-26
Visual Transformer and Deep CNN Prediction of High-risk COVID-19 Infected Patients using Fusion of CT Images and Clinical Data
Abbasi, H., Saberi Moghadam Tehrani, S., Zarvani, M., Amiri, P., Azmi, R., Ghods, Z., Nourozi, N., Raoufi, M., Safavi-Naini, S. A. A., Soheili, A., Abolghasemi, S., Gharib, M. J.
10.1101/2022.07.26.22278084 — Posted: 2022-07-26
The highly conserved RNA-binding specificity of nucleocapsid protein facilitates the identification of drugs with broad anti-coronavirus activity
Fan, S., Sun, W., Fan, L., Wu, N., Sun, W., Ma, H., Chen, S., Li, Z., Li, Y., Zhang, J., Yan, J.
10.1101/2022.07.26.501505 — Posted: 2022-07-26
Intranasal delivery of lipid nanoparticle encapsulated SARS-CoV-2 and RSV-targeting siRNAs reduces lung infection
Supramaniam, A., Tayyar, Y., Clarke, D. T., Kelly, G., Morris, K. V., McMillan, N. A., Idris, A.
10.1101/2022.07.25.501479 — Posted: 2022-07-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).